These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6143180)

  • 1. Oral treatment of systemic Pseudomonas aeruginosa infection with enoxacin.
    Hubrechts JM; Vanhoof R; Servais J; Toen R; Sacré J; van Gysel JP
    Lancet; 1984 Apr; 1(8381):860. PubMed ID: 6143180
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral enoxacin used to cure spinal osteomyelitis due to aminoglycoside-resistant Pseudomonas aeruginosa.
    Bailey RR; Newman E
    N Z Med J; 1985 Jun; 98(781):508. PubMed ID: 3859782
    [No Abstract]   [Full Text] [Related]  

  • 3. Enoxacin pharmacokinetics and efficacy in CF-1 mice.
    Chartrand SA; Scribner RK; Marks MI; Dice J
    J Antimicrob Chemother; 1987 Feb; 19(2):221-4. PubMed ID: 3553134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
    Bates SA; Elder MG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of enoxacin in a patient with cystic fibrosis.
    Miller MG; Ghoneim AT; Littlewood JM
    Lancet; 1985 Mar; 1(8429):646. PubMed ID: 2857989
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxacin raises plasma theophylline concentrations.
    Wijnands WJ; van Herwaarden CL; Vree TB
    Lancet; 1984 Jul; 2(8394):108-9. PubMed ID: 6145999
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic.
    Sugar A; Cohen MA; Bien PA; Griffin TJ; Heifetz CL; Mehta S
    Arch Ophthalmol; 1986 Aug; 104(8):1230-2. PubMed ID: 3461752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxacin distribution in human tissues after multiple oral administration.
    Malmborg AS; Rannikko S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone penetration of enoxacin in patients with and without osteomyelitis.
    Fong IW; Rittenhouse BR; Simbul M; Vandenbroucke AC
    Antimicrob Agents Chemother; 1988 Jun; 32(6):834-7. PubMed ID: 3166359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
    Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxacin in the treatment of sexually transmitted diseases.
    Siboulet A; Bohbot JM; Catalan F
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():119-24. PubMed ID: 3283097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates.
    Heifetz CL; Bien PA; Cohen MA; Dombrowski ME; Griffin TJ; Malta TE; Sesnie JC; Shapiro MA; Wold SA
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():29-42. PubMed ID: 3129392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
    Foot M; Williams G; Want S; Roe M; Quaghebeur G; Bates S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():97-103. PubMed ID: 3129393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxacin in lower respiratory tract infections.
    Wijnands WJ; van Griethuysen AJ; Vree TB; Van Klingeren B; van Herwaarden CL
    J Antimicrob Chemother; 1986 Dec; 18(6):719-27. PubMed ID: 3469179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
    Padeĭskaia EN; Mnatsakanian VE
    Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
    Papadakis JA; Samonis G; Maraki S; Boutsikakis J; Petrocheilou V; Saroglou G
    Chemotherapy; 2000; 46(2):116-21. PubMed ID: 10671762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.